Neovasc Inc. (NASDAQ:NVCN) – Stock analysts at Leerink Swann dropped their FY2016 earnings per share estimates for Neovasc in a research note issued on Tuesday. Leerink Swann analyst D. Antalffy now expects that the firm will post earnings of ($0.88) per share for the year, down from their prior estimate of ($0.47). Leerink Swann also issued estimates for Neovasc’s Q4 2016 earnings at ($0.08) EPS, Q3 2017 earnings at ($0.07) EPS, Q4 2017 earnings at ($0.08) EPS, FY2017 earnings at ($0.28) EPS and FY2018 earnings at ($0.17) EPS.

Earnings History and Estimates for Neovasc (NASDAQ:NVCN)

Neovasc (NASDAQ:NVCN) traded down 1.2782% during midday trading on Thursday, reaching $0.4943. The company’s stock had a trading volume of 554,899 shares. The firm’s market cap is $33.05 billion. The company has a 50 day moving average price of $0.55 and a 200 day moving average price of $0.74. Neovasc has a 1-year low of $0.37 and a 1-year high of $5.04.

A number of institutional investors have recently added to or reduced their stakes in the stock. Gagnon Advisors LLC increased its position in Neovasc by 46.2% in the second quarter. Gagnon Advisors LLC now owns 1,892,125 shares of the company’s stock valued at $975,000 after buying an additional 597,906 shares during the last quarter. Gagnon Securities LLC increased its position in Neovasc by 18.2% in the second quarter. Gagnon Securities LLC now owns 2,431,837 shares of the company’s stock valued at $1,253,000 after buying an additional 375,243 shares during the last quarter. Capital World Investors increased its position in Neovasc by 5.1% in the second quarter. Capital World Investors now owns 5,345,736 shares of the company’s stock valued at $2,808,000 after buying an additional 261,443 shares during the last quarter. Geduld E E increased its position in Neovasc by 133.3% in the third quarter. Geduld E E now owns 350,000 shares of the company’s stock valued at $184,000 after buying an additional 200,000 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in Neovasc by 20.7% in the first quarter. Geode Capital Management LLC now owns 25,929 shares of the company’s stock valued at $110,000 after buying an additional 4,446 shares during the last quarter. 23.63% of the stock is owned by hedge funds and other institutional investors.

About Neovasc

Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.

5 Day Chart for NASDAQ:NVCN

Receive News & Stock Ratings for Neovasc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc Inc. and related stocks with our FREE daily email newsletter.